ArticleJournal of vascular and interventional radiology : JVIR2012
Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
Article in Journal of vascular and interventional radiology : JVIR, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 38 citations in OpenAlex.
- Article
- The correlation between subcutaneous fat thickness and the incidence of chemoport-related infection.Infection prevention in practice · 2025Article
- Totally implantable venous access devices: A restrospective analysis of morbidity and risk factors in a hospital with multi-technique approaches.Surgery in practice and science · 2024Article
- Guidelines for Central Venous Port Placement and Management (Abridged Translation of the Japanese Version).Interventional radiology (Higashimatsuyama-shi (Japan) · 2023Review
- Review
- Single-session versus two-session placement of chest port and gastrostomy tube in patients with head and neck cancer: Is there any difference in the device-related early infection rates?Acta radiologica open · 2021Article
- Characteristics of infective endocarditis in a cancer population.Open heart · 2021Article
- Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer.Oncology letters · 2020Article
- The Rate of Catheter-Related Infections using Metal Coated Central Venous Catheters; a Letter to Editor.Archives of academic emergency medicine · 2019Article
- A Five-Year Data Report of Long-Term Central Venous Catheters Focusing on Early Complications.Anesthesiology research and practice · 2019Article
- Long-term outcomes of totally implantable venous access devices.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017Article
- Article
Corrections and comments
- Erratum issuedSeptkowitz, Kent A [corrected to Sepkowitz, Kent A]
Authors and funding
11 authors at 2 institutions in 2 countries.
Funding
Abstract
purposeTo determine the rate of early infection for totally implantable venous access devices (TIVADs) placed without antibiotic prophylaxis. MATERIAL AND
methodsA list of patients who underwent TIVAD placement in 2009 was obtained from the patient archiving and communication system (PACS). This list was cross-referenced to all patients who underwent TIVAD removal from January 1, 2009, through January 30, 2010, to identify TIVADs that were removed within 30 days of placement. Retrospective chart review was performed to record patient demographics, including age, sex, cancer diagnosis, and indication for removal. Concurrent antibiotic therapy, chemotherapy, and laboratory data before and within 30 days of placement were recorded. Central line-associated bloodstream infections (CLABSIs) were identified using U.S. Centers for Disease Control and Prevention (CDC) criteria.
resultsThere were 1,183 ports placed and 13 removed. CLABSIs occurred in seven (0.6%) patients within 30 days of placement. At the time of TIVAD placement, 81 (7%) patients were receiving antibiotics incidental to the procedure. One patient who received an antibiotic the day of implantation developed a CLABSI. Chemotherapy was administered to 148 (13%) patients on the day of placement.
conclusionsThe rate of early infection without antibiotic prophylaxis before TIVAD placement in the interventional radiology suite is < 1%. Based on these data, use of prophylactic antibiotics for TIVAD placement is not recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.